The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death

• Published in: Npj genomic medicine 2023-10, Vol.8 (1), p.29-29, Article 29
• Main Authors: Singer, Emma S., Crowe, Joshua, Holliday, Mira, Isbister, Julia C., Lal, Sean, Nowak, Natalie, Yeates, Laura, Burns, Charlotte, Rajagopalan, Sulekha, Macciocca, Ivan, King, Ingrid, Wacker, Julie, Ingles, Jodie, Weintraub, Robert G., Semsarian, Christopher, Bagnall, Richard D.
• Format: Article
• Language: English
• Subjects: 631/208/1516; 631/208/2489/1512; Bioinformatics; Biomedical and Life Sciences; Biomedicine; Blood; Cardiomyocytes; Cardiomyopathy; Cardiovascular disease; Coronary artery disease; Gene Function; Gene Therapy; Genetic screening; Heart; Heart diseases; Human Genetics; Internal Medicine; KCNQ1 protein; Long QT syndrome; Pathogenicity; Potassium channels (voltage-gated); Ribonucleic acid; RNA; Splicing
• ISSN: 2056-7944; 2056-7944
• DOI: 10.1038/s41525-023-00373-w

There is an incomplete understanding of the burden of splice-disrupting variants in definitively associated inherited heart disease genes and whether these genes can amplify from blood RNA to support functional confirmation of splicing outcomes. We performed burden testing of rare splice-disrupting variants in people with inherited heart disease and sudden unexplained death compared to 125,748 population controls. ClinGen definitively disease-associated inherited heart disease genes were amplified using RNA extracted from fresh blood, derived cardiomyocytes, and myectomy tissue. Variants were functionally assessed and classified for pathogenicity. We found 88 in silico-predicted splice-disrupting variants in 128 out of 1242 (10.3%) unrelated participants. There was an excess burden of splice-disrupting variants in PKP2 (5.9%), FLNC (2.7%), TTN (2.8%), MYBPC3 (8.2%) and MYH7 (1.3%), in distinct cardiomyopathy subtypes, and KCNQ1 (3.6%) in long QT syndrome. Blood RNA supported the amplification of 21 out of 31 definitive disease-associated inherited heart disease genes. Our functional studies confirmed altered splicing in six variants. Eleven variants of uncertain significance were reclassified as likely pathogenic based on functional studies and six were used for cascade genetic testing in 12 family members. Our study highlights that splice-disrupting variants are a significant cause of inherited heart disease, and that analysis of blood RNA confirms splicing outcomes and supports variant pathogenicity classification.